135 (Nimodipine 30 mg)
Pill imprint 135 has been identified as Nimodipine 30 mg.
Nimodipine is used in the treatment of subarachnoid hemorrhage; ischemic stroke; migraine prevention and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nimodipine 30 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 30 mg
- Prescription only
- Drug Class:
- Calcium channel blocking agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
D&C Yellow No. 10
Note: Inactive ingredients may vary.
More about nimodipine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews – Add your own review/rating
- Drug class: calcium channel blocking agents
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.